Product NDC: | 0703-4156 |
Proprietary Name: | Idarubicin Hydrochloride |
Non Proprietary Name: | idarubicin hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; idarubicin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-4156 |
Labeler Name: | Teva Parenteral Medicines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065036 |
Marketing Category: | ANDA |
Start Marketing Date: | 20021001 |
Package NDC: | 0703-4156-11 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4156-11) > 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0703-4156-11 |
Proprietary Name | Idarubicin Hydrochloride |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4156-11) > 20 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0703-4156 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | idarubicin hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20021001 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc |
Substance Name | IDARUBICIN HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |